New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

Learn more about GLP-1 pills and how they may be more convenient and cost-effective than the injections.

It depends. There have been a few clinical trials on the impact of GLP-1 injectable medications on weight loss with different ...

The new oral drug costs as little as $149 a month out of pocket and is expected to broaden access as demand for GLP-1 weight-loss treatments grows.

MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from ...

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

The Wegovy pill comes in tablet form—and is the first U.S. Food & Drug Administration (FDA)-approved GLP-1 to do so. Its ...

People taking weight-loss drugs are likely to regain the weight they have lost within two years of stopping the medications, ...

In the first human trial of a new therapeutic, a single injection of lepodisiran reduced levels of lipoprotein(a), or Lp(a), to undetectable levels for nearly one year, according to late-breaking ...